Trimethoprim-sulfamethoxazole-induced refractory hypoglycaemia successfully treated with octreotide.

Mah, Jordan Kit; Negreanu, Daniel; Radi, Suhaib; Christopoulos, Stavroula

Mah, Jordan Kit; Negreanu, Daniel; Radi, Suhaib; Christopoulos, Stavroula.

Afiliação

Mah JK; Department of Internal Medicine, McGill University, Montreal, Quebec, Canada.
Negreanu D; Department of Internal Medicine, McGill University, Montreal, Quebec, Canada.
Radi S; Endocrine Oncology, Princess Margaret Cancer Center, University of Toronto, Toronto, Ontario, Canada suhaibradi@gmail.com.
Christopoulos S; Division of Endocrinology, Department of Medicine, King Saud bin Abdulaziz University for Health Sciences College of Medicine, Jeddah, Saudi Arabia.

BMJ Case Rep ; 14(5)2021 May 07.

Article em En | MEDLINE | ID: mdl-33962920

Assuntos

Anti-Infecciosos; Hipoglicemia; Glucose; Humanos; Hipoglicemia/induzido quimicamente; Hipoglicemia/tratamento farmacológico; Octreotida/uso terapêutico; Combinação Trimetoprima e Sulfametoxazol/efeitos adversos

Palavras-chave

drugs: endocrine system; endocrinology; general practice / family medicine; infections; unwanted effects / adverse reactions

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Hipoglicemia / Anti-Infecciosos Idioma: En Ano de publicação: 2021 Tipo de documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Hipoglicemia / Anti-Infecciosos Idioma: En Ano de publicação: 2021 Tipo de documento: Article